203935-39-1

203935-39-1 structure

Name: Helioxanthin derivative 5-4-2
Chemical Name: 10-(1,3-benzodioxol-5-yl)-8,9-dihydro-7H-[1,3]benzodioxolo[4,5-f]isoindol-7-one
CAS Number: 203935-39-1
Molecular Formula: C₂₀H₁₃NO₅
Molecular Weight: 347.32100
Catalog: Signaling Pathways Anti-infection HBV
Create Date: 2018-06-27 23:07:39
Modify Date: 2024-01-14 10:32:14
Helioxanthin derivative 5-4-2 is an analogue of helioxanthin, exhibites significant in vitro anti-HBV activity with EC50 of 0.08 uM in HepG2.2.15 cells.IC50 value: 0.08 uM (EC50) [1][2]Target: Anti-HBVHelioxanthin derivative 5-4-2 had potent anti-HBV activities in HepG2.2.15 cells, with the EC50s of 1 and 0.08 microM, respectively. The lamivudine-resistant HBV, L526M/M550V double mutant strain, was also sensitive to helioxanthin and 5-4-2. This class of compounds not only inhibited HBV DNA, but also decreased HBV mRNA and HBV protein expression. The EC50 of HBV DNA inhibition was consistent with the EC50 of HBV 3.5 Kb transcript inhibition, which was 1 and 0.09 microM for helioxanthin and 5-4-2 respectively.

Name	10-(1,3-benzodioxol-5-yl)-8,9-dihydro-7H-[1,3]benzodioxolo[4,5-f]isoindol-7-one
Synonyms	10-benzo[1,3]dioxol-5-yl-8,9-dihydro-1,3-dioxa-8-aza-dicyclopenta[a,g]naphthalen-7-one 10-(1,3-benzodioxol-5-yl)-8,9-dihydro-7H-1,3-benzodioxolo[4,5-f]isoindol-7-one Helioxanthin derivative 5-4-2

Description	Helioxanthin derivative 5-4-2 is an analogue of helioxanthin, exhibites significant in vitro anti-HBV activity with EC50 of 0.08 uM in HepG2.2.15 cells.IC50 value: 0.08 uM (EC50) [1][2]Target: Anti-HBVHelioxanthin derivative 5-4-2 had potent anti-HBV activities in HepG2.2.15 cells, with the EC50s of 1 and 0.08 microM, respectively. The lamivudine-resistant HBV, L526M/M550V double mutant strain, was also sensitive to helioxanthin and 5-4-2. This class of compounds not only inhibited HBV DNA, but also decreased HBV mRNA and HBV protein expression. The EC50 of HBV DNA inhibition was consistent with the EC50 of HBV 3.5 Kb transcript inhibition, which was 1 and 0.09 microM for helioxanthin and 5-4-2 respectively.
Related Catalog	Signaling Pathways >> Anti-infection >> HBV Research Areas >> Infection
References	[1]. Yeo H, et al. Synthesis and antiviral activity of helioxanthin analogues. J Med Chem. 2005 Jan 27;48(2):534-46. [2]. Li Y, et al. Inhibition of hepatitis B virus gene expression and replication by helioxanthin and its derivative. Antivir Chem Chemother. 2005;16(3):193-201.